Hillary Clinton accuses Canadian drugmaker Valeant of 'predatory pricing'

Hillary Clinton has stepped up her battle against predatory drug pricing in her bid to become the next U.S. president -- and she is setting her sights on Valeant Pharmaceuticals.

See Full Article

In a new campaign ad on her YouTube page, the front-runner for the Democratic presidential nomination vows to go after the Quebec-based drugmaker.

Valeant has been accused of gouging patients on drug costs -- allegations it has denied.

The ad posted Monday cites the case of a woman who has been taking a brand name medication since the 1980s that, at one time, it says cost about $180 for 10 shots.

The name of the medication is not disclosed in the ad, which appears to have been filmed at a town hall-type campaign stop in January.

The ad shows Clinton waving a letter and saying the cost of the woman's latest refill has shot up to $14,700 for the same 10 vials.

"The company is called Valeant Pharmaceuticals. I am going after them," Clinton tells the meeting to a round of applause.

"This is predatory pricing and we're going to make sure it is stopped."

Valeant said after it became aware of the patient's story in January, it contacted her to determine whether it could help cover the costs of the medication as part of a patient assistance program.

"She informed us that her insurance provider covers the drug, so it is not a significant out-of-pocket expenditure for her," Valeant said in a statement Tuesday.

Valeant also said there has been a generic version of the drug available since 2003 and that its share of the overall market for the medication has declined to less than one per cent.

"Whenever the sales volume of a drug declines, manufacturers must consider pricing adjustments to keep production of the drug viable," Valeant said. "Patients are able to choose generic versions of the drug, however, at significantly lower prices."

The company, one of several companies under investigation as the U.S. Congress looks at price increases for certain specialty drugs, has seen its share price plummet to well under $100 from above $346 last summer. On Tuesday, the stock fell $6.55 to settle at $87.94 on the Toronto Stock Exchange.



Advertisements

Latest Economic News

  • Cooling measures already affecting hot Toronto housing market: survey

    Economic CTV News
    The recent intervention by the Ontario government to cool the Toronto-area’s hot housing market is already having an impact on sellers and buyers plans for the year, according to a new poll. At the end of April, Ont. Source
  • Why is the American teen summer job disappearing? [Video]

    Economic Toronto Sun
    WASHINGTON — It was at Oregon’s Timberline Lodge, later known as a setting in the horror movie “The Shining,” where Patrick Doyle earned his first real paycheque. He was a busboy. The job didn’t pay much. But Doyle quickly learned lessons that served him for years as he rose to become the CEO of Domino’s, the pizza delivery giant: Source
  • Waiting for a Canadian housing crash? Warren Buffet bets against it buying 38% stake in Home Capital Group Inc.

    Economic Toronto Sun
    Warren Buffett's deal to back Home Capital Group Inc. does more than support a struggling mortgage lender -- it's a vote of confidence for a housing market that everyone from investors to global ratings companies say is a bubble ready to burst. Source
  • CIBC looks to generate quarter of earnings from U.S.

    Economic CBC News
    CIBC closed its acquisition of Chicago-based PrivateBancorp on Friday, securing its foothold in the U.S. where CEO Victor Dodig said the bank hopes to one day generate a quarter of its earnings. The Canadian bank now earns roughly five per cent of its profits in the U.S. Source
  • CIBC closes acquisition of U.S.-based PrivateBancorp

    Economic CTV News
    TORONTO -- CIBC closed its acquisition of Chicago-based PrivateBancorp on Friday, securing its foothold in the U.S. where CEO Victor Dodig said the bank hopes to one day generate a quarter of its earnings. The Canadian bank (TSX:CM) now earns roughly five per cent of its profits in the U.S. Source
  • Consumer demand for debt as high as it has ever been, Equifax says

    Economic CBC News
    Canadians' appetite for debt is as insatiable as ever, a new report from credit monitoring firm Equifax says. Equifax calculates that Canadian consumers owed $1.729 trillion at the end of the first quarter, an increase of 6.9 per cent in a year. Source
  • Sears Canada store closures expected to have little impact on RioCan

    Economic CTV News
    NEW YORK -- Sears is closing another 20 stores as the ailing retailer tries to turn around its business. Real estate investment trust Seritage, which owns the 20 real estate properties, confirmed the closings-- 18 Sears stores and two Kmart stores -- in a government filing Friday. Source
  • Ontario rent increases capped at 1.8 per cent next year

    Economic CTV News
    TORONTO - Landlords in Ontario will be able to increase rents up to 1.8 per cent next year, as rent controls are expanded under the Liberal government's housing plan. The annual rent increase guideline is the maximum amount a landlord can boost a tenant's rent without needing the approval of the Landlord and Tenant Board. Source
  • Norsat International investors approve takeover bid from Chinese firm

    Economic CBC News
    ?Norsat International Inc. says its securityholders have voted to approve a controversial takeover of the company by Chinese company Hytera Communications Co. Ltd. The Canadian satellite communications firm says its securityholders voted 72.53 per cent in favour of the offer of $11.50 US per share. Source
  • Cost of Muskrat Falls hydro project rises by another billion, CEO says

    Economic CTV News
    ST. JOHN'S, N.L. -- Costs for the beleaguered Muskrat Falls hydro development in Labrador are up by another $1 billion. Nalcor Energy CEO Stan Marshall says the new price tag is $12.7 billion with financing. Source